Efficacy of adipose derived stem cells in management of chronic ulcers: clinical and laboratory study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201709002519185

Enrollment

100

Registered

2017-08-14

Start date

2017-09-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Chronic ulcers

Interventions

Injection of stem cells derived from fat tissue

Conventional dressing methods

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age: 15-55 years old. 2. Chronic non-healing ulcer... Diabetic and trophic ulcers

Exclusion criteria

Exclusion criteria: 1. Age less than 15 or older than 55 years old. 2. Immunocompromised patients. 3. Cancer patients. 4. Mental patients.

Design outcomes

Primary

Measure	Time frame
Evaluation the efficacy of ASCs therapy in treatment of non-healing ulcers	—

Secondary

Measure	Time frame
Diameter of ulcer;State of floof of ulcer;Amount of stem cells needed;Histological findings	—

Countries

Egypt

Contacts

Public ContactYoussef Saleh

Head of plastic surgery department

plasticclinic66@gmail.com01001166118

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026